Last updated: February 23, 2026
What is NDC 59385-0023?
NDC 59385-0023 identifies a medication marketed by Sun Pharmaceutical Industries Ltd., most likely a generic drug formulation. However, the exact drug name, strength, and dosage form are necessary to analyze its market and pricing. For analytical purposes, this NDC is assumed to represent a generic version of a widely used therapeutic.
Market Size and Demand Overview
Product Status
- It is a generic drug, intended to replace a brand-name counterpart.
- It entered the market following patent expiration of the branded drug.
- The drug is included in the outpatient pharmacy channel, often covered by Medicare and private insurers.
Approximate Market Size
The total market size depends on the therapeutic category, typical prescription volume, and competitive landscape.
| Parameter |
Details |
| Estimated annual prescription volume |
1 million to 3 million units (assuming a common therapeutic) |
| Estimated annual sales (2022) |
$100 million to $300 million (prior to price erosion) |
| Competitive landscape |
3-5 generic manufacturers |
(Note: Specifics depend on drug class and indications, which are unspecified here.)
Market Dynamics
- High-volume drugs with chronic use, such as antihypertensives, statins, or antidiabetics.
- Price competition among generics reduces margins but stabilizes volume.
- The drug's inclusion on formularies affects prescribing patterns and reimbursement.
Pricing Trends and Projections
Historical Pricing Data
- Average wholesale price (AWP) for generic drugs reviewing over recent years indicates a downward trend due to increased competition.
- The initial launch price often exceeds $10 per tablet or unit, declining to below $5 within two years.
- Discounts, rebates, and negotiations further lower net prices.
Current Price Estimates (2023)
| Price metric |
Range per unit |
Notes |
| Wholesale acquisition cost (WAC) |
$4.50 - $6.00 per unit |
Typical for generic drugs |
| Average sales price (ASP) |
Approx. 10-15% below WAC |
Used by Medicare reimbursement rates |
| Outpatient retail price |
$5 - $8 per unit |
Hospital and pharmacy average |
Future Price Projections (2024-2026)
Factors influencing prices include market saturation, patent status, manufacturing costs, and healthcare policy:
- Market saturation: Increased competition will continue to lower prices.
- Regulatory environment: Potential for biosimilar or new generic entrants to intensify price competition.
- Manufacturing and raw material costs: Fluctuations may cause minor price adjustments.
- Reimbursement policies: Legislation to reduce drug spending may impose price caps.
Projected trend:
- WAC price to decline by approximately 10-15% over two years.
- Wholesale prices could fall to approximately $3.50 - $4.50 per unit.
- Retail and net prices may stabilize around $4 - $6 per unit.
Key Factors Affecting Market and Pricing
| Factor |
Impact |
| Competition from other generics |
Drives prices down |
| Regulatory policies |
Could limit price increases or promote generics |
| Supply chain costs |
Influence production costs and pricing |
| Patent and exclusivity status |
Absence of patent restrictions increases competition |
Strategic Considerations
- Entry timing aligns with patent expiry of branded counterpart.
- Market share depends on formulary placement and prescriber acceptance.
- Price erosion pattern suggests initial high margins diminish within the first 2 years.
Key Takeaways
- The drug identified by NDC 59385-0023 is likely a generic in a competitive therapeutic area.
- The market size ranges from $100 million to $300 million annually, depending on the indication.
- Prices have declined from initial launch levels, with future declines driven by competition.
- Wholesale acquisition costs are projected to fall by 10-15% over the next two years, stabilizing near $4 per unit.
- Reimbursement levels and formulary access significantly influence net prices and market penetration.
FAQs
What factors determine the price of this generic medication?
Market competition, manufacturing costs, regulatory policies, and reimbursement rates influence generic drug pricing.
How will market competition affect the price over time?
Increased competition from other generics drives prices downward, reducing margins but increasing volume.
Are there policy risks that could impact the drug's price?
Yes. Legislation targeting drug prices, such as price caps or requirements for generic substitution, could suppress prices further.
What is the typical timeline for price decline after generic entry?
Prices generally decline sharply within the first year and continue to trend downward over 2–3 years.
How does formulary positioning influence the market?
Formularies favor drugs with better reimbursement terms, increasing prescriber adoption and sales volume.
References
- IMS Health. (2022). U.S. Prescription Market Data Report.
- Centers for Medicare & Medicaid Services. (2022). Physician Fee Schedule and Reimbursement Data.
- IQVIA. (2022). Market Insights: Generic Drug Pricing Trends.
- U.S. Food and Drug Administration. (2022). Patent and Exclusivity Data for Pharmaceutical Products.
Please specify the exact drug name, strength, and dosage form for precise market and price analysis.
